Kamada Analyst Ratings
H.C. Wainwright Maintains Kamada(KMDA.US) With Buy Rating, Maintains Target Price $11
Buy Rating Affirmed for Kamada on Strong Clinical and Financial Performance
Earnings Call: Kamada Limited Sees Growth With a Revenue Increase of 13% Compared to Previous Year
Kamada Ltd. (KMDA) Q2 2024 Earnings Call Transcript Summary
Kamada Ltd. Reports Substantial Growth in 2024
Kamada 2Q Rev $42.5M >KMDA
Express News | Kamada Reiterates FY24 Revenue Guidance Of $158M - $162M (Est $159.60M) And Adjusted EBITDA Of $28M - $32M
Kamada Q2 2024 GAAP EPS $0.08 Beats $0.06 Estimate, Sales $42.47M Beat $39.70M Estimate
Press Release: Kamada Reports Strong Second Quarter and First Half 2024 Financial Results With Year-Over-Year 6-Month Top-Line Growth of 18% and a 68% Increase in Profitability
Kamada Reports Strong Second Quarter and First Half 2024 Financial Results With Year-Over-Year 6-Month Top-Line Growth of 18% and a 68% Increase in Profitability
Here's the Major Earnings Before the Open Tomorrow
Kamada Q2 2024 Earnings Preview
Sidoti Events, LLC's Virtual August Micro-Cap Conference
Kamada Preps for Q2 Financial Results Reveal
Kamada | 6-K: Report of foreign private issuer (related to financial reporting)
Kamada to Announce Second Quarter and First Half Ended June 30, 2024 Financial Results and Host Conference Call on August 14, 2024
Kamada Draws Buy at Stifel on Underappreciated Potential
Stifel Maintains Kamada(KMDA.US) With Buy Rating, Maintains Target Price $18
Kamada Initiated at Buy by Stifel